The growing sophistication of tumor molecular profiling has helped to slowly transition oncologic care toward a more personalized approach in different tumor types, including in bladder cancer. The ...
Earlier in May 2026, NeoGenomics, Inc. announced it would present eight scientific abstracts at the 2026 ASCO Annual Meeting in Chicago, highlighting advances in hematologic malignancy testing, ...
Serum tumor markers (STMs), including alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG), are currently used in management of patients with germ cell tumors (GCTs). STMs in a substantial ...
CHARLOTTE, N.C. — Circulating tumor DNA (ctDNA) from patients with gastrointestinal (GI) cancers can reflect treatment response, spare some additional treatment, or signal potential remission in those ...
A blood test that detects tumor DNA circulating in the bloodstream may help select the most effective treatment options for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results